A Mixed Methods Randomized Controlled Trial Evaluating the Hans Kai Program

计划入组 90 人 · 首次发布于 2019 年 5 月 14 日

Hans Kai: Impact of a Peer Lead Community Health Program on Behavior Change, Mental Health, Health Efficacy and Social Support Comparative Control Study

首次发布于 2018 年 3 月 1 日

Allergen Provocations- HCA Children's Hospital

计划入组 8,000 人 · 首次发布于 2020 年 4 月 2 日

haNK cells

gp140 vaccine(Crucell Holland BV)

ANs-30

Van Den Broek, Dr Hans

United States

AgomAb Therapeutics

Sana Biotechnology

United States

Amplifica Appoints Hans Hofland, Ph.D., as Chief Development Officer and William Humphries to Board of Directors

Roche Announces Leadership Changes as Head of Pharma R&D Hans Clevers Retires

Roche Unfazed by Side Effects in Early Obesity Drug Trial, Eyes 'Best-in-Class' Potential